dc.contributor.author | Ak, Naziye | |
dc.contributor.author | Tastekin, Didem | |
dc.contributor.author | Duran, Ali | |
dc.contributor.author | Karabulut, Senem | |
dc.contributor.author | DOĞAN, İzzet | |
dc.contributor.author | USUL AFŞAR, ÇİĞDEM | |
dc.contributor.author | Karabulut, Mehmet | |
dc.date.accessioned | 2021-12-10T09:45:56Z | |
dc.date.available | 2021-12-10T09:45:56Z | |
dc.identifier.citation | Karabulut S., DOĞAN İ., USUL AFŞAR Ç., Karabulut M., Ak N., Duran A., Tastekin D., "Does nutritional status affect treatment tolerability, chemotherapy response and survival in metastatic gastric cancer patients? Results of a prospective multicenter study in Turkey", JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021 | |
dc.identifier.issn | 1078-1552 | |
dc.identifier.other | av_118165b6-3fb8-44e2-a62e-d19bfbfaad75 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/168432 | |
dc.identifier.uri | https://doi.org/10.1177/1078155220987291 | |
dc.description.abstract | Background | |
dc.language.iso | eng | |
dc.subject | Pharmacology (medical) | |
dc.subject | Oncology | |
dc.subject | Pharmacy | |
dc.subject | Drug Guides | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Pharmacology | |
dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
dc.title | Does nutritional status affect treatment tolerability, chemotherapy response and survival in metastatic gastric cancer patients? Results of a prospective multicenter study in Turkey | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF ONCOLOGY PHARMACY PRACTICE | |
dc.contributor.department | İstanbul Teknik Üniversitesi , , | |
dc.contributor.firstauthorID | 2604545 | |